As obesity is a risk factor for at least thirteen malignancies such as pancreatic and colon cancer through dysregulation of insulin and hormonal signaling pathways, the incidence of obesity-associated cancers is anticipated to increase concurrently with rising rates of obesity[2]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.